Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$33.54 - $40.55 $78,114 - $94,440
-2,329 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$34.54 - $47.25 $339,044 - $463,806
-9,816 Reduced 80.82%
2,329 $93,000
Q1 2021

May 12, 2021

BUY
$42.51 - $63.78 $91,226 - $136,871
2,146 Added 21.46%
12,145 $546,000
Q4 2020

Feb 10, 2021

SELL
$45.3 - $60.27 $105,594 - $140,489
-2,331 Reduced 18.91%
9,999 $565,000
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $440,952 - $584,994
9,293 Added 305.99%
12,330 $585,000
Q2 2020

Aug 12, 2020

BUY
$46.85 - $61.05 $39,213 - $51,098
837 Added 38.05%
3,037 $179,000
Q3 2019

Nov 12, 2019

SELL
$59.06 - $72.15 $13,347 - $16,305
-226 Reduced 9.32%
2,200 $132,000
Q4 2018

Feb 14, 2019

SELL
$43.37 - $59.54 $1,474 - $2,024
-34 Reduced 1.38%
2,426 $131,000
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $1,843 - $2,309
-43 Reduced 1.72%
2,460 $127,000
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $73,683 - $92,172
-1,818 Reduced 42.07%
2,503 $104,000
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $80,137 - $100,080
1,818 Added 72.63%
4,321 $190,000
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $114,036 - $149,103
2,503
2,503 $127,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.